DEMED MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DEMED MEDICAL
Largest movements
- Current investments +€34,319
new in 2025: €34,319
- Cash -€8,750
down €8,750 (-19.9%), from €43,955 to €35,205
mainly Current investments (-€34,319) and Receivables within one year (-€2,017)
- Receivables within one year +€2,017
up €2,017 (+498%), from €405 to €2,422
- Reserves +€22,628
up €22,628 (+95.5%), from €23,700 to €46,329
- Other debts +€6,328
up €6,328, from €0 to €6,328
- Tax, wage and social debts -€978
down €978 (-74.3%), from €1,316 to €338
of which Taxes: -€978
- Gross operating margin -€4,929
down €4,929 (-12.7%), from €38,883 to €33,954
- Taxes +€1,405
up €1,405 (+15.3%), from €9,194 to €10,599
- Financial charges +€628
up €628 (+312%), from €201 to €829
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €44,687 | €71,968 | +€27,281 | +61.0% |
| Fixed assets | 21/28 | €114 | €0 | -€114 | -100% |
| Tangible fixed assets | 22/27 | €114 | €0 | -€114 | -100% |
| Plant, machinery and equipment | 23 | €114 | €0 | -€114 | -100% |
| Current assets | 29/58 | €44,573 | €71,968 | +€27,395 | +61.5% |
| Amounts receivable within one year | 40/41 | €405 | €2,422 | +€2,017 | +498% |
| Other amounts receivable | 41 | €405 | €2,422 | +€2,017 | +498% |
| Current investments | 50/53 | - | €34,319 | +€34,319 | |
| Cash at bank and in hand | 54/58 | €43,955 | €35,205 | -€8,750 | -19.9% |
| Deferred charges and accrued income | 490/1 | €213 | €23 | -€190 | -89.3% |
| Total equity and liabilities | 10/49 | €44,687 | €71,968 | +€27,281 | +61.0% |
| Equity | 10/15 | €42,250 | €64,879 | +€22,628 | +53.6% |
| Contributions | 10/11 | €18,550 | €18,550 | = | 0.0% |
| Reserves | 13 | €23,700 | €46,329 | +€22,628 | +95.5% |
| Distributable reserves | 133 | €23,700 | €46,329 | +€22,628 | +95.5% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €2,437 | €7,089 | +€4,653 | +191% |
| Amounts payable within one year | 42/48 | €2,437 | €7,089 | +€4,653 | +191% |
| Trade debts | 44 | €1,120 | €423 | -€697 | -62.2% |
| Suppliers | 440/4 | €1,120 | €423 | -€697 | -62.2% |
| Taxes, remuneration and social security | 45 | €1,316 | €338 | -€978 | -74.3% |
| Taxes | 450/3 | €1,316 | €338 | -€978 | -74.3% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €0 | €6,328 | +€6,328 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €287 | €114 | -€173 | -60.1% |
| Other operating charges | 640/8 | €912 | €654 | -€258 | -28.3% |
| Gross operating margin | 9900 | €38,883 | €33,954 | -€4,929 | -12.7% |
| Operating profit (loss) | 9901 | €37,684 | €33,185 | -€4,498 | -11.9% |
| Financial income | 75/76B | €1,259 | €871 | -€388 | -30.8% |
| Recurring financial income | 75 | €1,259 | €871 | -€388 | -30.8% |
| Financial charges | 65/66B | €201 | €829 | +€628 | +312% |
| Recurring financial charges | 65 | €201 | €829 | +€628 | +312% |
| Profit (loss) for the period before taxes | 9903 | €38,742 | €33,228 | -€5,514 | -14.2% |
| Income taxes | 67/77 | €9,194 | €10,599 | +€1,405 | +15.3% |
| Profit (loss) for the period | 9904 | €29,548 | €22,628 | -€6,920 | -23.4% |
| Profit (loss) for the period to be appropriated | 9905 | €29,548 | €22,628 | -€6,920 | -23.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.